Top 10 blueprintmedicines.com Competitors

missionbio.com

Discover how Mission Bio’s Tapestri Platform integrates genotype and targeted gene expression analysis in a single assay, offering drug developers unprecedented insight into tumor heterogeneity, mechanism of resistance, and biomarker development.

ab-science.com

WHAT ARE THE INNOVATIONS FROM AB SCIENCE RESEARCH?   Research by AB Science regarding masitinib, its flagship molecule, is aimed at providing innovative therapeutic solutions in three main areas of medicine: oncology, inflammatory diseases, and neurological disorders.  AB Science hypothesized that mast cells play a key role in tumorigenesis (for example, pancreatic, prostate, colorectal); chronic…

arcusbio.com

Stay up to date with Arcus for information about clinical trials, research, and company news that matters most to you. Sign up now.

sanofi.com

Sanofi is a research & development-driven, AI-powered healthcare biopharma company committed to improving lives through innovative medicines & vaccines.

lexogen.com

Lexogen is a transcriptomics company focusing on the development of innovative kits and software for RNA-Seq.

ayvakit.com

Review answers to common questions about gastrointestinal stromal tumor and how AYVAKIT treats PDGFRA GIST. See ISI and PI for more information.

ayvakithcp.com

Analyze the design of the PIONEER clinical trial and how it measured ISM symptom relief and mast cell burden. See ISI and PI for more information.

caltagmedsystems.co.uk

European distributor of biological reagents for diagnostics and research.

thenativeantigencompany.com

Through much of 2020, SARS-CoV-2 accumulated mutations at a slow and steady rate. However, as global cases approached 100 million by the end of the year, more extensive variants began to emerge, exhibiting new pathogenic traits. In this article for Clinical Lab Products, Dr Andy Lane explains what is known about the new SARS-CoV-2 variants and discusses the role of serology in variant characterisation.